Skip to main content
Fig. 5 | BMC Psychiatry

Fig. 5

From: Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database

Fig. 5

Distribution of hypnotics segmented by psychiatric comorbidities and age (a) and sex (b) among long-term users of hypnotics. The distributions of hypnotics prescribed to long-term users of hypnotics in 2018–2019 were segmented according to psychiatric comorbidities × age (a) and psychiatric comorbidities × sex (b). Values are % of patients. Neurocognitive disorders = Alzheimer’s disease. BZD benzodiazepine, MOA mechanism of action, MRA melatonin receptor agonist, ORA orexin receptor antagonist, z-drug non-benzodiazepine

Back to article page